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Abstract 
Mammalian development involves a complex system of regulatory signals and reactions, 
leading to the creation of distinct tissues with specific structures and functions controlled by 
various gene expression profiles. Tissue-specific gene expression is by controlled specific 
combinations of transcription factors and cofactors that dictate cell differentiation via activation 
and repression of genes in mammalian cells. 
Whole genome microarray analyses of fibroblasts have revealed candidate genes that may 
serve as master regulators of fibroblast identity, such as Prrx l and Snai2, that activate downstream 
genes such as Bmp3, Twist, Shox2, Cfos, Slug, Sema3A, Sppl, and Col l a l .  A previous study 
showed that Prrx I and Snai2 play important roles in activating expression of fibroblast identity 
using somatic cell hybrids as model systems . Based on these results, we sought to examine the role 
of Prrx l and Snai2 in affecting the phenotyope of liver-derived cells using hepaloma cells as a 
model system. 
Expression plasmids containing Prrx 1 and Snai2 expression cassettes were transfected 
separately into Fgl 4 rat hepatoma cells using a standard transfection technique, then G41 8-resistant 
clones were selected (pooled and individually) and monitored for over-expression of Prrx 1 and 
Snai2. RNA was extracted and used to synthesize cDNA. Quantitative real-time polymerase chain 
reaction (qPCR) was carried out using specific primer pairs and signals normalized to GAPDH 
mRNA levels. In addition, we observed alteration morphology and cell migration using Scratch 
Assays. 
qPCR analysis revealed that both Prrx 1 and Snai2 were successfully over-expressed in pooled 
Fg14 transfectants and individual clones compared to non-transfected cells. Next we monitored 
iv 
expression of several genes known to be important in liver and fibroblast function. Results show 
that Snai2 activated several genes (Twist,Cfos,Shox2,and Bmp3) in Fgl4 hepatoma cells. 
Although several other fibroblast genes (SEMA3A and Sppl) were relatively unaffected.Prrxl 
overexpression resulted in activation of (Cfos,Twist,Shox2,Bmp3,and Col I al) expression in Fgl 4 
hepatoma, but (SEMA3A and Spp 1) were unaffected. 
Based on these findings we hypothesized that overexpression of fibroblast-specific 
transcription factor Prrxl and Snai2 would result in loss of hepatoma phenotype. We therefore 
monitored expression of a panel of liver -specific genes using qPCR analysis. Results show that 
several liver related genes are repressed by these transcription factors, leading to partial loss of the 
hepatic phenotype. We observed that the cells re-acquired a spindle-shaped morphology and more 
significantly an enhanced migration capability, which is reminiscent of parental fibroblast cells. In 
conclusion, these results suggest that candidate core Prrx 1 and Snai2 serve as a useful starting 
point for studying transcriptional control of cell identity and reprogramming of mammalian cell 
types. 
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Chapter 1 
Introduction 
1 .1 .  Gene regulation in eukaryotes 
Understanding of cellular development requires a strong knowledge of gene regulation. 
Multiple molecular mechanisms regulate cellular differentiation and functional specialization 
(Neph et al, 2012). Inappropriate activation or repression of key genes can result in birth defects, 
cancer, and even death. Even though individual cells of multicellular organisms generally have the 
same genome, each cell type has dissimilar sets of active genes, producing distinct sets of proteins 
thereby ensuring each cell type is specialized for its role. Consequently, gene regulation defines 
cell structure and function, which contribute to overall functions in the organism. Gene regulatory 
factors that control the expression of genomic information are diverse and complex. 
Gene expression is defined as the process by which the genetic code - the nucleotide 
sequence - of a gene is used to direct protein synthesis (Tomizawa et al, 1997). Cell identity is 
controlled by the activity of transcription factors (TFs) that recognize and bind particular 
sequences in the genome and regulate gene expression (D' Alessio et al, 2015). Mechanisms 
responsible for establishment and maintenance of tissue-specific gene expression have been well 
studied over several decades using different methods (Chen et al,.2014, Christoforou et al,.2017, 
L'ecuyer et al,.1999). The primary regulation of gene expression is at the level of transcription 
(Neph et al. 2012, Kaplan et al. 2009). Chromatin packaging has a direct effect on transcriptional 
activity by limiting access to TFs, and eukaryotic gene regulation is dependent on chromatin 
structure in all stages of development (Bannister and Kouzarides 2011, Karlie et al. 20 I 0). 
Selective transcription is the basis for tissue-specific gene expression (Reviewed in Lodish et al. 
1 
1995, Davis et al. 1973). Factors that play a role in gene regulation include tissue/sequence-specific 
TFs, general TFs (RNA polymerases with pre-transcriptional initiation complex factors such as 
TFIIA, TFIIB, TFIID, TFIIE), chromatin regulators, co-activators, co-repressors and other 
regulatory proteins (Chi and Carey 1996, Ha et al. 1993). 
Transcription initiation requires cis-regulatory DNA sequences that include the promoter 
and enhancer regions which are recognized by specific DNA binding domains of TFs for gene 
activation (De Simone et al, 1987, Li et al, 1988). These TFs often contain domains which are 
responsible for functional interactions. Examples of commonly known domains are 
homeodomains (encoded by homeobox sequences), zinc finger motifs, and winged helices (Fork 
head box). TFs also commonly interact with additional proteins such as co-factors and other 
regulators that do not bind DNA sequences directly (Studitsky et al.1995). 
TFs bind directly to specific target sequences in a highly specific manner (Gourdeau 
and Fournier 1990). Many studies have shown that mutations in TF binding sites lead to a loss 
or decrease of gene activation (for example-Costa et al. 2003). Epigenetic phenomena 
including chromatin remodeling, histone modification and environmental conditions also play 
a major role in gene regulation. DNA methylation, histone acetylation and heterochromatin 
modeling all affect gene activity (Annunziato et al. 2000, Freeman-. et al. 2000). The 
repression of transcriptional machinery is due to the inactive chromatin state resulting from 
methylation of tissue-specific promoters and histone de-acetylation. (Ben-Shushan et al. 1992, 
Yoshida et al. 1995). During gene expression, the TFs are known to de-methylate tightly 
packed DNA to induce DNase I-hypersensitive sites (Cam et al. 2009, Nahon et al. 1988). 
2 
Gene activation/repression of most, if not all, genes in the genome are controlled not 
simply by a single factor, but through cooperative action of the numerous factors (Figure 1). 
In addition, gene expression is affected by transcription (initiation, elongation, and 
termination), mRNA processing, transport, translation, and protein stability (Hewish and 
Burgoyne 1973). Two well-known families of cis acting transcriptional regulatory DNA 
elements include (a) a promoter, composed of a core promoter and close (proximal) regulatory 
elements and (b) distal regulatory elements, that contain enhancers, silencers, insulators, or 
locus control regions (LCR) (see Fig. 2). These cis-acting transcriptional regulatory elements 
contain recognition sites for trans-acting DNA-binding TFs, which function either to enhance 
or repress transcription (Maston et al. 2006). 
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Figure 1 :  Types of gene regulation including chromatin structure, translation of mRNA, 
RNA processing, RNA stability, and post-translation modification. 
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Figure 2. Schematic of a typical gene regulatory region. The promoter, which is composed of 
a core promoter and proximal promoter elements, typically spans less than I kb pairs. Distal 
(upstream) regulatory elements, which can include enhancers, silencers, insulators, and locus 
control regions, can be located up to 1 Mb pairs from the promoter. These distal elements may 
contact the core promoter or proximal promoter through a mechanism that involves looping out 
the intervening DNA. 
1.2. Gene Regulatory Elements: 
1- Chromatin Remodeling and Histone Modifications. 
Chromatin structure is regulated by modification of either the DNA, or the histone proteins 
associated with the DNA. Chemical modification of histones includes phosphate, methyl, or acetyl 
groups (Lodish et al, 2000, Dahlin et al. 2015). DNA methylation tends to occur in area called 
CpG islands, often located in promoter regions of the genes, containing stretches with a high 
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frequency of CG bases. Deacetylated histones and highly methylated (hypermethylated) DNA 
regions are transcriptionally inactive and tightly coiled (Marchesi and Bagella 2013). 
2- Enhancers and Transcription. 
Enhancers are regulatory DNA sequences that stimulate the transcription of a gene 
physically placed at a distant location from the promoter. Enhancers come into nearby proximity 
with target promoters with the looping away of intervening sequences (see Fig. 2). Enhancers are 
usually some hundred base pairs long and cover clusters of different 4- to 8-bp DNA sequences 
that are recognized by several TFs. If TFs bind to enhancers, there is subsequent activation of 
transcription by recruitment of coactivators and RNA polymerase II (Spitz and Furlong 2012). 
3- The Promoter and the Transcription Machinery. 
The principal function of the promoter region is to bind the TFs that drive the initiation of 
transcription. The promoter region is immediately upstream of the coding sequence. The TAT A 
box resides within the promoter region located just upstream of the transcriptional start site. 
Transcription occurs when RNA polymerase binds to the transcription initiation complex. To 
initiate transcription, a TFUD is the first to bind to the TAT A box (Nikolov and Burley 1997). 
Binding of TFIID recruits other TFs, including TFIIB, TFIIE, TFIIF, and TFI IH to the TAT A box. 
RNA polymerase can then bind to its upstream sequence when this complex is assembled. Next, 
when bound along with the TFs, RNA polymerase is phosphorylated. This releases part of the 
protein from the DNA to activate the transcription initiation complex and places RNA polymerase 
in the correct orientation to begin transcription. DNA-bending protein brings the enhancer 
sequences, which can be quite a distance from the gene, in contact with TFs and mediator proteins 
(Figure 3) (Lodish et al, 2000). 
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Figure 3. An enhancer is a DNA sequence that promotes transcription. Each enhancer is made 
up of short DNA sequences called distal control elements. Activators bound to the distal control 
elements interact with mediator proteins and TFs. Two different genes may have the same 
promoter but different distal control elements, enabling differential gene expression. 
1.3. TFs and Gene Regulation. 
TFs ultimately direct recruitment of RNA polymerases to initiate transcription gene 
expression. Tissue-specific TFs play an essential role in defining cell type (Wilson et al. 2010). 
These factors are components of Transcriptional Regulatory Networks (TRNs) in somatic cells 
and are understood to maintain tissue identity. Recent discoveries have established that genes are 
not completely activated or deactivated through TFs, only increased or decreased in expression 
(Neph et al. 2012). Therefore, there is a high degree of interaction with other gene products to 
control expression of a single gene, so maintaining cell specific subnetworks is required to 
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coordinate biological functions and maintain cellular phenotypes. Most TFs are not related 
structurally, but they have important and diverse functions and may cross-talk during cell 
differentiation and lineage specification processes (Marchesi and Bagella 2013 ). Recent studies 
have suggested that expression of these lineage specific transcription factors can convert adult 
somatic cells from one type to another (Chen et al,.2014 ). Determination of cell fate is determined 
by lineage specific TFs regulating the expression of tens or hundreds of target genes. Thus, role of 
TFs in regulation of tissue specific gene expression is critical. 
1.4. Fibroblasts. 
Fibroblasts are the most common type of cells found in connective tissues. These cells synthesize 
a collection of extracellular molecules and collagen fibers (extracellular matrix) that are used to 
maintain a structural framework for many tissues and play an important role of tissue repair in 
animals (Darby et al. 2014). The extracellular matrix; is the basis for connective tissues in animals 
(Sixt, 2012). Connective tissues are structural frameworks which support organs. A fibroblast can 
therefore also be defined in simple terms as a cell that manufactures and maintains connective 
tissues. 
Connective tissue is one of four main types of tissues in the body grouped into fibroblasts, 
cartilage cells, bone cells, fat cells and smooth muscle cells, all of which are specialized for the 
secretion of collagenous extracellular matrix and are together responsible for the architectural 
framework of the body. Connective-tissue cells play an essential part in the support and repair of 
almost every tissue and organ, and the adaptability of their differentiated character is a significant 
feature of the responses to many types of damage (Alberts et al .2002). Fibroblast morphology is 
based on a branched cytoplasm which surrounds a speckled nucleus having an elliptical shape 
containing two or more nucleoli. Although fibroblasts produce multiple collagens in all tissues of 
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the body, synthesis and deposition of collagen are not often addressed in the identification of 
fibroblasts since fibroblasts globally remodel the collagen matrix (Tamariz and Grinnell 2002). 
Rather, fibroblasts can be defined based on morphological characteristics that can differ by 
location within the organism. Therefore, the most important feature of fibroblasts is their 
morphologic heterogeneity with diverse appearances depending on their location and activity. 
Fibroblast morphology includes flat, spindle shaped cells with various processes deriving from the 
main cell body. Fibroblasts have a unique characteristic: lack a basement membrane, whereas most 
permanent cell types such as those of the heart contain a basement membrane (Souders et al. 
2009). 
The terms" fibroblast" and "fibrocyte" are used to describe different forms of the same 
cell; fibroblasts are the active state of the cell while fibrocytes are the Jess active state of the cell. 
An active fibroblast can be differentiated from inactiv� ones by examining their endoplasmic 
reticulum, which is abundantly rough compared to inactive fibrocytes with a condensed rough 
endoplasmic reticulum (Pilling et al, 2009). Although there is a tendency to refer to these different 
forms as fibroblasts, the suffix "-blast" in cellular biology is used in reference to a cell in an 
activated state of metabolism. The appearance of fibroblasts depends on their location within the 
body and their activity making them morphologically heterogeneous. Within this framework, 
fibroblasts which are ectopically transplanted can retain positional memory of the location where 
they previously resided (Hannan et al.,2018). 
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Fibroblasts in Development. 
The development of a fibroblasts is a complex subject due to their wide variety of locations 
and origins. During organogenesis, understanding where the cells come from is an important 
endeavor and essentially aids in knowing how the cells migrate to their location within the tissue. 
Depending on the stage of development, fibroblasts can arise from various sources. Fibroblasts are 
mesenchymal cells which occur in all tissue types that derive from the mesoderm during 
embryonic development (Kendall and Feghali 2014). Fibroblasts are believed to originate from 
mesoangioblasts which have the ability to differentiate into mesodermal tissues (fibroblasts) or 
endothelial cells (Souders et al. 2009). The origin of this progenitor (mesoangioblasts) in the bone 
marrow is the hematopoietic stem cell. Hematopoietic stem cells express many lineage markers of 
vascular cells such as VEGF-R2 and CD34. Additionally, studies have indicated that in adult 
animal cells, the fibroblast population is contributed by pericytes and mesenchymal stem cells of 
the bone marrow (Cossu and Bianco 2003). Albert et al. (2002) stated that, in certain conditions 
and situations, the process of epithelial-mesenchymal transition (EMT), whereby epithelial cells 
give rise to fibroblasts, is a crucial source of fibroblasts development. EMT is the evolution 
through which epithelial cells lose their polarity. 
Fibroblast Functions. 
The primary function of fibroblasts is the maintenance of the structural integrity of the 
connective tissues, through the secretion of extracellular matrix proteins such as glycoproteins, 
proteoglycans and collagen. Apart from their function as structural components in connective 
tissues, fibroblast have a significant role in immune response to tissue injury. Following tissue 
injury, fibroblasts respond to wound healing through proliferating and by migration due to 
chemotaxis to the sites of tissue injury to restructure the extracellular matrix (ECM) as a scaffold 
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for tissue regeneration. Furthermore, fibroblasts serve functions in inflammation and immune cell 
recruitment to sites of tissue injury (Kendall and Feghali-Bostwick 2014) 
According to Darby et al. (2014), fibroblasts are early players in initiating irritation in 
response to invading microorganisms. In the process of wound healing, fibroblasts in an acute 
wound exhibit an immediate response to factors delivered by activated platelets. Some of the 
released factors include platelet-derived growth factor-BB, proteases, and chemokines (Chiquet et 
al. 2015). Fibroblasts, by presenting receptors on their surfaces, are able to induce chemokine 
synthesis, which triggers immune cells to respond by activating cascading events that clear the 
intrusive microorganisms. 
Another important function of fibroblasts is monitoring any deviation from tissue 
homeostasis which is commonly referred to as changes in mechanical stress. The process by which 
fibroblasts detect any variations in the mechanical pressure within their extracellular matrix is 
through integrin connectors which substantially link the extracellular matrix with the cell's 
cytoskeleton enabling transmission of force in both directions (Chiquet et al., 2015; Darby et al., 
2014). Externally applied force results in an extracellular strain which in tum is transmitted to the 
cytoskeleton of the cell. Fibroblasts then counter the applied pressure through cytoskeleton traction 
due to the increase in cytoskeletal stress. 
Fibroblasts are also significant in tumor mediation, since immune regulation of tumors is 
largely determined by the remodeling of the extracellular matrix which has a responsibility of 
regulating a variety of functions of the vital organs. Sewell-Loftin et al. (2017) state that 
extracellular matrix remodeling is very common in many tumor types derived from epithelial cells. 
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Types of Fibroblasts and Their Functions. 
As mentioned above, fibroblasts are extensively distributed connective tissue cells that are 
found in all vertebrate organisms, so there are a variety of fibroblasts types having distinct 
functions in animals. Fibroblasts produce connective tissues which are important in supporting the 
organs in which they are produced. Fibroblasts can also show phenotypes that depend on their 
tissue origin and functional state (Slany et al., 2014). In this thesis, different phenotypes of 
fibroblasts and their functions are described. 
The most abundant cell types of periodontal connective tissues are the gingival fibroblasts 
(GF). The GF has a primary function of repairing periodontal tissues and can also be used in stem 
cells for periodontal tissue engineering (Lee et al. 2013). 
GFs have a critical role in the maintenance of gingival tissues and subsequently are their 
major constituents. Human gingival fibroblasts express a variety of molecules on their surfaces 
including protease-activated receptor-I. Other molecules expressed by GF include COSS, CD99, 
and CD63 .. Apart from the GF, another type of fibroblast in humans is the cardiac fibroblasts; the 
cardiac fibroblasts are one of the permanent cellular constituents of the heart in addition to 
myocytes and endothelial cells. The function of the cardiac fibroblast is to maintain the normal 
operation of the cardiac tissue and similarly in cardiac remodeling during conditions such as 
hypertension (Souders et al. 2009). In addition, cardiac fibroblasts are involved in the secretion of 
cytokines and growth and factors (Souders et al., 2009). 
Another type of fibroblasts are dermal fibroblasts. These are located in the dermis of the 
skin and facilitate skin recovery post-injury. Slominski et al. (2016) established that human dermal 
fibroblasts express CYP 11A1 10, which can interact with vitamin D3 to produce unique 
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CYPI !Al-dependent hydroxyderivatives. Additionally, the dermal fibroblasts produce protein 
molecules fibronectin and laminin which are constituents of the extracellular matrix. 
Yet another type of human fibroblasts is the human uterine fibroblasts (HUF), which are 
isolated from the uterine wall. In conjunction with additional cells, such as immune cells and 
epithelial cells, fibroblast cells in the uterus support an immune system which is essential for the 
optimization of conditions for fertilization and pregnancy (Braundrneier et al.2012). 
Finally, Human Vas Deferens Fibroblast (HVDF) and Human intestinal fibroblast (HIF) 
are other types of fibroblasts isolated from the vas deferens and human intestinal tissues, 
respectively. Table I describes various types of fibroblast, their functions, and from where they 
are isolated. 
Table 1. Fibroblasts types, their location, and function. 
Type hllctio• Souree 
1 
Gingival Fibroblasts Repairing periodontal Gingival tissues 
tissues 
2 
Cardiac Fibroblast Maintaining normal Heart 
function of the cardiac 
and its subsequent 
remodeling. 
3 Guaranteeing skin 
Dermal Fibroblast recovery from injury Dermal tissues 
4 Optimizing conditions 
for fertilization and 
The Human Uterine Fibroblast (HUF) pregnancy m Human uterine 
conjunction with other wall tissues 
cells. Remodeling the 
uterine tissues 
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5 Human Vas Deferens Fibroblast Maintain the structure Vas deferens 
(HVDF) of vas deferens tissues 
6 Initiate intestinal 
Human Intestinal Fibroblast epithelial cell (JEC) Human intestinal 
growth tissues 
7 Provide structural Human lung 
Human Lung Fibroblast (HLF) integrity to the lung tissues 
8 Maintain the structural Urinary bladder 
Bladder Fibroblast integrity of the bladder 
Moreover, fibroblasts have the ability to secrete several different types of fibrous proteins which 
are described in table 2, depending on where they are and what type of connective tissue they are 
form. 
Table 2. Fibroblasts secrete several different types of fibrous proteins, their location, and 
function. 
1 Collagen 
2 Elastin 
3 Reticular fibers 
Strong fiber. Tendons 
Collagen is the most abundant 
protein in the human body. Ligaments 
Provides tensile and compressive 
stren h for or ans and tissues. 
Resilient protein. Skin 
Helps tissues return to their 
previous shape after they have Smooth muscle 
been stretched 
The scaffold form for cells liver, spleen, and 
lymph nodes are 
Make collagen type 111 loaded with 
reticular fibers 
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Marker genes and specific TFs driving fibroblast identity. 
There are a variety of genes that are essential in determining fibroblast identity. One such 
gene is Tbx20, which is a gene that encodes the TF TBX20 in cardiac fibroblasts. Studies have 
established that Tbx20 is instrumental in the early development of the heart and the remodeling of 
the yolk sac vasculature (Furtado et al. 2016). Furtado et al. (2014) further argue that Tbx20 and 
other genes such as Gata4, Mef2c, Tbx5, Mmp3, Hand2 and Nkx2-5 are highly enriched in the 
cardiac fibroblast. Another gene driving fibroblast development is a smooth muscle actin (aSMA) 
whose expression is the hallmark of mature myofibroblasts (Hsiaa et al. 2016). 
Fibroblast genes have been studied in this laboratory using a cell hybrid model system 
combined with whole genome analysis. Evidence suggests that specific genes such as Prrx 1 and 
Snai2 have the ability to act as master regulators that can activate fibroblasts function. Other 
candidate genes identified which appear to be markers of fibroblast identity include Bmp3, Twist, 
Shox2, Cfos, Sema3a, and Sppl. 
Recent results by Ray et al. (2016), suggest that SNA12 (Snail Family Transcriptional 
Repressor 2) is an influential activator or repressor of expression of genes in mammalian cells. 
SNAI2 expression is ubiquitous and may affect tumor invasion as it alters the expression of E­
cadherin and vimentin genes. According to Mistry et al. (2014), SNAl2 is an inducer of the 
epithelial to mesenchymal transition (EMT) which mediates cell migration during development 
and tumor invasion. Moreover, SNAl2 gene is zinc finger protein (Mistry et al, 2014). This protein 
is involved in the process through which epithelial cells lose their cell polarity and subsequently 
acquire invasive and migratory properties. SNAI2 is therefore responsible for mediating cell 
migration during development or the invasion of tumor (Pioli et al. 2015 and Mistry et al. 2014). 
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Cell migration plays a very vital role in many biological processes such as cancer growth, 
tissues repair, and embryogenesis. For example, fibroblasts have a significant influence in 
remodeling of the extracellular matrix, especially during tumor invasion related to epithelial cells, 
and SNAl2 acts as a master regulator of fibroblast function during such a process. As a mediator 
of cell migration, SNAI2 regulates epidermal progenitor cells which together with the fibroblast 
maintain adult skin homeostasis. 
Another protein, PRRXJ (Paired-Related Homeobox 1) (Zhu et al. 2017) is a master 
regulator of IPF (idiopathic pulmonary fibrosis) fibroblasts and an instrumental gene driving 
fibroblasts identity. Froidure et al. (2016) argue that PRRXI isofonns are upregulated in IPF 
fibroblasts and their overexpression inhibits the expression of platelet-derived growth factor 
(PDGF) migration thereby promoting IPF survival after serum deprivation (Froidure et al. 2016). 
The regulation of mesenchymal cell fate is carried out by PRRXI TFs and simultaneously stand 
at the center of a network coordinating fibroblasts differentiation. Subsequently, this makes 
PRRXl a master regulator of fibroblast identity. 
According to Zhu et al. (2017) and F roidure et al. (2016), the modulation of fibroblast 
phenotype is directed by PRRX l and consequently involved in IPF (idiopathic pulmonary 
fibrosis). Fibroblast to myofibroblast differentiation is a very significant aspect of IPF and is 
controlled by PRRX I ,  since the overexpression of PRRXI promotes the control, survival and 
migration of Jung fibroblasts (Froidure et al., 2016). 
The family of paired-related homeobox TFs, which includes Prrx l a, Prrxl b, and Prrx2, is 
implicated in regulation of mesenchymal cell fate, including myogenesis and skeletogenesis 
(Baowen et al.2012). Collagen, type I, alpha 1 (COLI A l )  and fibroblast specific protein 1 (FSP-
1) are highly expressed in fibroblasts, with FSP-1 being the standard marker for fibroblast identity, 
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since the promoter/enhancer region driving this gene is active in fibroblasts (Strutz et al 1 995). 
Osterreicher et al. (20 1 1 )  suggested that levels of FSP-1 expression in different organs is a marker 
of fibroblasts from different organs when they undergo remodeling of their tissues. Additionally, 
FSP-1 is used to identify fibroblast derived from the extracellular matrices of several organs 
including the heart, lungs, or liver. 
Another marker of fibroblasts identity is a type III intermediate filament protein (vimentin) 
which subsequently has been used as a marker for mesenchymal-derived cells such as fibroblasts. 
Furthermore, a better understanding of complex pathologies associated with fibroblasts would be 
helped by methods to positively identify fibroblasts under a wide range of cellular states using 
their shape with a combination of positive staining with vimentin (Goodpaster et al.2008). 
Similarly, Fibroblasts Surface Antigen (FSA) is one of the main glycoprotein antigens 
identified in connective tissues. Prolyl-4-hydroxylase is another marker used for fibroblast identity 
as a result of its use as a putative marker for collagen-producing cells. 
Finally, recent research shows that discoidin domain receptor 2 (DDR2) is expressed 
specifically by cardiac fibroblasts and is important in a variety of cellular functions; such as 
activating expression of the collagen receptor (a cell surface receptor) as well as growth, migration, 
and differentiation that can represent markers of fibroblast cells (Souders et al., 2009). 
Fibroblast specificity. 
During tissue remodeling and cell migration, differentiated cell types that have lost tissue­
specific cues are considered to be drivers of fibroblast identity (Strutz et al., 1995). Subsequently, 
fibroblast are fully differentiated cells having their own identity and functions even though 
fibroblasts of different origin show heterogeneity in abundance, behavior, and identity. 
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Additionally, signaling intermediate proteins and specific transcriptions factors are reported to 
stimulate the conversion of fibroblasts to different cell types such as rnyoblasts (Tapscott et al., 
1998), osteoblasts (Rutherford et al., 2002), and adipocytes (Wu et al., 1996). According to Strutz 
(1995), fibrosis (which is a tissue degenerative disease) is a result of the excessive synthesis of 
fibroblast cells and deposition of extracellular matrix substances such as proteoglycans, collagen 
types I and Ill, and fibronectin. Instances of fibrosis in tissues such as liver, skin, and lung show 
excessive fibroblast differentiation which affects the surrounding tissues. In fact, for development 
and maintenance of several tissue specific phenotypes require a strong relationship with fully 
differentiated fibroblasts. Existing research indicate that blood, bone and cartilage are highly 
dependent on fibroblast cells with fibroblasts playing a crucial role in bone, cartilage, and blood 
tissue specialization (Baksh et al., 2004 ). 
Fibroblasts in Disease. 
One of the primary function of fibroblast is the secretion of the extracellular matrix proteins 
to maintain the structural integrity of the tissues. However, when the accumulation of extracellular 
matrix in the connective tissues is undesirable, the resultant condition is termed fibrosis, a common 
connective tissue disease. Fibrosis is the thickening and scaring of connective tissues leading to 
notably scleroderma (systemic sclerosis). The process of connective tissue scarring and deposition 
in healing and the pathological state of surplus deposition of fibrous tissue is well be described 
through fibrosis. The function of fibroblasts in the development of fibrosis includes their activation 
and stimulation, initiated when immune cells release soluble factors which activate fibroblasts. 
The occurrence of fibrosis can be witnessed in different parts of the body due to inflammation or 
damage. Some common examples include lung (pulmonary fibrosis) and heart. Katsumata et al. 
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(2017) suggested that liver fibrosis that is the most common outcome of chronic liver injuries of 
different etiologies by accumulation of extracellular matrix proteins. 
The role of fibroblasts in diseases can also be examined through cancer-associated 
fibroblasts (CAFs) which is a cell type that promotes tumorigenic aspects through remodeling of 
the extracellular matrix (Sewell-Loftin et al., 201 7). Most cancers originate from epithelial cells 
that can be the result of fibrosis (Hinck and Nathke 2014). For example, non-cancerous cells 
cooperate with cancer cells, with fibroblasts affecting the biology of a tumor. 
Also, certain biological processes of fibrous cells promote the spread of cancers by 
regulating the microenvironment of a tumor, affecting tumor size and tumor invasion of adjacent 
tissues (metastasis). The most important of these vital processes are wound healing, inflammation, 
fibrosis, angiogenesis, and their associated biochemical machinery (Mueller and Fusenig, 2004 ). 
Liu et al., (201 1 )  reported that metastasis occurs when fibroblast::; secrete the ECM proteins that 
modulate tumor progression and remodeling of the connective tissue surrounding a tumor. This 
result plays a critical role in cancer progression by allowing cancerous cells to be released from a 
contained tumor into the vascular system. 
Fibroblasts in Medicine. 
Fibroblasts play an important role in mammals. Not only are they responsible in the 
synthesis of the extracellular matrix, but also collagen, providing structure of tissues in animals 
and helping to repair damaged tissues. They can also migrate and accumulate in different areas to 
facilitate wound healing especially following injury. There is much interest to understand how to 
repair body tissues damaged by illnesses and injuries using fibroblasts. 
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Studies by Kendall and Feghali-Bostwick (2014) have shown that fibroblasts are not only 
effector cells in fibrosis, but also are potential targets for several therapies. Various disorders 
have been described as being targets of potential strategies which could inhibit or completely end 
fibrotic responses. Several fibroblast-specific molecules that could be of use in developing 
therapies include Endostatin, vitamin d3, and components of the Wnt-like signal transduction 
pathway. Endostatin is a super inhibitor of angiogenesis, which has gone through several clinical 
tests and emerged as an agent which can prevent the growth of a tumor mass. It not only inhibits 
vessel formation, but also endothelial cell proliferation. Endostatin is a purple peptide, which is a 
wide spectrum inhibitor that could interfere with the action of growth factors like endothelial 
growth factor and fibroblast growth factor. 
Vitamin D, is another area of therapeutic interest, as it serves several functions. The main 
function is to regulate the absorption of minerals in the intestines, calcium and concentrations of 
phosphate in the blood. It also helps in maintaining the integrity of bones in the body. Studies 
however have shown a linear correlation between the absence of Vitamin D3 and many extra­
osseous disorders. The improvement of vitamin D3 presence in the body is therefore a medicinal 
strategy to treat fibrotic disorders. In additionally, Wnt is a framework signaling protein which 
regulates the production, migration and determination of the cell-fate. The ligands of this protein 
enable frizzled receptors and encourage the activation of glycogen synthase kinase. Eventually, 
the end result is the contribution of collagen production and wound healing. 
With fibroblasts being the most abundant cells in the skin, making up about 70% of the 
dermal cells, they constantly maintain the skin structure and contribute to healing post -injury. 
Chronic wounds such as diabetic foot ulcers are not easily managed using conventional treatment 
since fibroblasts sequestered from a diabetic foot ulcer display low cellular activity. While 
19 
fibroblasts derived from normal human tissues, exhibit high proliferative possibility and slow 
growth factor production, fibroblasts from diabetic foot ulcer exhibit low levels of intercellular 
communication in which growth factors orchestrate the wound healing process (Han et al.2009). 
According to the study carried out by Han et al. (2009), fresh fibroblasts allografts showed 
positive therapeutic outcome for diabetic foot ulcers. The study by Han et al. gives a feasible 
medical practice through which cultured fibroblast allografts could be used to successfully 
improve problematic wounds by secreting numerous growth factors and cytokines that regulate 
cell proliferation, modify the inflammatory process, and induce angiogenesis. Additionally, the 
transplanted fibroblasts also produce three-dimensional extracellular matrices which are 
comprised of collagen and other proteins. Even with a viable approach of treating diabetic foot 
ulcer using transplanted fibroblasts, Han et al. still suggests further investigation to determine the 
optimal number of transplanted fibroblasts and the fate of the fresh fibroblasts. Other curative 
properties of fibroblasts are still under investigation with researchers proposing numerous 
medicinal uses for them, such as in non-surgical lift procedures. 
1.5. Models to Understand Differential Gene Expression: 
1- Cell Culture as a Model. 
Cell culture is a feasible model by which the mechanisms of differential gene expression 
can be understood. Cell culture is the removal of plant or animal cells from their natural residence 
and placed in an artificial environment that is favorable for their growth. The removal of the cells 
can be from tissues that are then disaggregated by mechanical means or enzymatic means before 
cultivation. Additionally, the cells can be derived from a cell line that has already been established. 
The application of cell culture is mainstream in molecular and cellular biology through the 
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provision of outstanding models for studying cell physiology and biochemistry. Cell culture is also 
applied in biomedical manufacture through development and screening of drugs. 
Cell culture provides a means through which information from a gene used to manufacture 
protein or other molecules is used to understand regulation of gene expression. Cell culture 
provides a basis by which cell physiology and biochemistry can be studied. Moreover, the ability 
to grow a large number of cells or viruses in a cultured environment is significant in improving 
knowledge of the genetic material of a cell, thus enabling the use of information provided by 
genomic and transcriptomic project to describe gene product functions and interactions. 
2- Fibroblasts as a Model. 
The most common type of connective tissue in animals is fibroblasts cells that make up the 
structural framework composed of the extracellular matrix and collagen. Subsequently, fibroblasts 
are a favorite subject for cell biological studies because they are the easiest cells to grow in culture . .  
Fibroblast transfection is a commonly used method, and fibroblast transfection reagents are 
commercially available. Gene expression is frequently studied using fibroblast cells and tissues. 
Skin fibroblast cells are easily acquired and can be cultured in a conducive environment to grow 
large amounts of the cell and simultaneously maintain their stability for several generations 
(Logotheti et al., 201 5). Nowinski et al. (2004) provided a model through which gene expression 
can be understood and studied using fibroblast cells. The study is based on gene expression of 
fibroblast cells throughout the wound restorative progression in which keratinocytes communicate 
with fibroblasts, thereby determining different gene expression to reestablish a functional 
epidermis. This study suggests that keratinocytes disturb the activity of fibroblasts gene expression 
throughout the process of epithelialization. Therefore, fibroblasts serve as a model which can be 
used to understand differential gene expression. 
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3- Somatic Cell Hybridization. 
One model used to understand fibroblast-specific gene function is through the use of 
somatic cell hybrids. Somatic hybrids have been used as a significant tool to examine the extinction 
of tissue-specific traits for over 40 years (Barski et al.1960). This technique was among the first 
used to study the molecular mechanisms underlying tissue specific gene expression. Somatic cells 
hybrids are culture lines which are formed through the fusion of somatic cells derived from 
different or the same species. One viable process by which cell hybrids are achieved is by fusing 
cells in the presence of Sendai virus which facilitates the fusion to form a hybrid cell (See Figure 
4 ). Sendai virus is used as a fusogen, since spontaneous fusion of cells occur at a low frequency 
(Marro et al.2014). To guarantee that the fused cells are real hybrids, karyotype analysis is 
performed on parental and hybrid cells hence the hybrid cells have twice the chromosome average 
of the parental cells. Hence, a hybrid cell contains a full complement of the chromosomes from 
the original cell parents. 
Formation of 
hybrids 
Proliferation 
of hybrids to 
form colonies on 
selective medium 
Hybrid colony A 
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Figure 4. Flow chart showing fusion of somatic cells hybrids. 
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(http.//wiki20.com/wikiffranscription factor) 
Immediately after a successful fusion of mouse X human cells, human chromosomes are 
more commonly eliminated. However, studies have indicated that intra-species hybrid (rat 
hepatoma and rat fibroblast) have a stable genotype that maintain tetraploid karyotype a well as 
expression profiles and are suitable as a model to understand gene regulation. For example, using 
somatic cell hybridization, extinction of lineage-specific genes has been studied in the pituitary 
cells and liver. Somatic cell hybridization has been used as a technique for studying repression of 
lineage specific genes in muscles, liver, pituitary cells, and myeloid cells (Ringertz and 
Savage. 1976). 
In somatic cell hybrids, some tissue specific genes are silenced, a phenomenon which is 
known as extinction (Bulla et al., 2012). Extinction includes regulatory mechanisms that inhibit 
the expression of specific genes for specific cell types during development. Gene silencing occurs 
due to the loss of tissue-enriched TFs. 
Somatic cell hybridization has been studied intensively in our lab to study extinction of 
fibroblast-specific functions to provide an understanding of the regulation of fibroblast-specific 
gene and the upstream regulators. Recently, Ray et al, (2016) studied genome-wide gene silencing 
of fibroblast cells using the somatic cell hybridization approach. Here, rat hepatoma cells and rat 
fibroblasts were fused to generate FR (2) hybrids. The advantage of using intra-species cells to 
generate hybrids is that the resultant hybrid cell demonstrates a stable genotype with minimal 
chromosomal loss. 
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1.6. DNA Microarray Analysis. 
DNA microarray (DNA chip or biochip) analysis is a tool used to study the expression of 
all genes of a tissue in a single experiment (Hihara et al., 2001). The practical application of DNA 
microarrays is in its ability to diagnose diseases or test genetic predisposition. Microarray analysis 
utilizes microchips that contain anchored arrays of short DNA probes; labelled nucleic acids are 
applied to the arrays and subsequent imaging and data processing carried out to monitor 
hybridization to specific probes. Each data point produced by a DNA microarray hybridization 
experiment represents the ratio of expression levels of a particular gene under two different 
experimental conditions (Brown et al., 2000). Through a DNA microarray analysis, differential 
patterns of gene expression can be studied thereby giving clues to their biological roles. 
Through microarray experiments, genes of comparable functions have been studied to take 
on similar expression patterns thus offering biological significance and assigning functions to 
genes. A DNA microarray analysis can also be used to examine different gene expression in human 
fibroblast cells. Furtado et al. (2014) showed that DNA rnicroarray analysis is essential in 
understanding cardiac fibroblast function to establish operational therapeutic managements for 
heart failure. Microarray analysis datasets have important issues when it comes to data noise; 
however, Furtado et al. (2014) state that using a robust lmFit method is instrumental as it is noise­
tolerant as regarded within the bioinformatics community. 
One viable case study in which DNA microarray has been utilized is by Ray (2016) using 
whole genome microarray experiments conducted using RNA isolated from parental cell hybrid 
line. This allowed for analysis if 3 1 ,042 target genes. Ray (2016) confirm the repression of genes 
in somatic cell hybrids by q-RT-PCR. The results of the study indicated fibroblast TFs, Prrxl and 
Snai2 are repressed in hybrid cells (Ray, 201 6). 
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1.7. Cell Migration. 
The development and maintenance of multicellular organisms require cell migration (Ray, 
2016). During embryonic development, immune response, and wound healing processes, 
coordinated cell movements take place in distinct directions to specific locations. Cells are 
activated in response to specific external signals (mechanical and chemical). Errors during cell 
migration have detrimental outcomes leading to conditions such as intellectual disability, tumor 
formation, and metastasis. Additionally, abnormal cell migration during embryogenesis leads to 
birth defects while lack of cell migration within the body of an adult negatively affects wound 
healing process and inflammation response (Sixt, 201 2). An understanding of the cell migration 
process is important to development of novel therapeutic strategies which when initiated can help 
mitigate invasive tumor cells. 
Staying within a highly viscous environment, cells need to produce force to help them 
move and can achieve such movement through different mechanisms. Prokaryotic organisms, as 
well as less complex eukaryotic cells such as the sperm cell, make use of cilia or flagella for 
locomotion. Complex eukaryotic cell migration consists of different migration mechanisms with 
the two most common migration scenarios entailing blebbing motion and crawling motility. As 
fibroblasts synthesize extracellular matrix, they can undergo migration when responding to injury 
or inflammation. Fibroblasts move in a type of ameboidal-type cell migration; this is a type of cell 
migration which is accomplished by the extension and retraction of a pseudopodium. Sixt (2012) 
argue that fibroblasts migrate in 2-D (two dimensional) surfaces by developing lamellipodia-actin 
abundant extensions. 
Hulkower and Herber (201 1 )  describe various methods through which cell migration is 
studied including Scratch Assays, Transmembrane Assays, Microfluidic Chamber Assay, and Cell 
25 
Exclusion Zone Assays. According to Hulkower and Herber (201 1), the Scratch Assay is a simple 
low-cost method which is used to measure cell migration in a controlled environment outside an 
organism (in vitro). The Scratch Assay method entails capturing images at several time points after 
creating a scratch in a cell monolayer. Perfonning this procedure allows quantification of the rate 
of cell migration. Another method for studying cell migration is Transmembrane Assay which uses 
a chamber separated into two compartments by a porous filter membrane to allow the study of 
leukocyte migration in response to antibody-antigen complexes as a chemotactic agent (Hulkower 
& Herber, 20 1 1 ). Through this assay, a solution which is to be tested for chemotactic activity is 
seeded on one side while the cells are seeded on the other side of the membrane. Finally, the 
number of cells which have migrated to the other side of the membrane in response to the 
chemotactic agent are counted microscopically. The Microfluidic Chamber Assay uses 
microfluidic systems whereby cells are introduced in a small port and stick to the chamber bottom 
while the test agents are added to the larger port hence providing a basis by which cells are imaged 
to measure migration in response to the test agent (Hulkower & Herber, 201 1 ). Cell Exclusion 
Zone Assays are similar to Scratch Assays and Microfluidic Assays. However, the Cell Exclusion 
Zone Assays is characterized using a barrier to prevent cultured cells from growing and making 
healthy blood cells ( engraftment). 
1.8. Objective and the Goals of this study. 
A previous study using whole genome microarray analysis and somatic cell hybridization 
showed that Prrx 1 and Snai2 play important roles in activating expression of fibroblast identity in 
somatic cell hybrids as model systems (Ray, 2016). To extend these studies, we addressed the 
questions of whether fibroblast specific transcrption factors Snai2 and Prrxl could reprogram 
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hepatoma cells to a fibroblast phenotype. To this end, the objective is to overexpress these genes 
and monitor both liver- and fibroblast- specific gene expression. 
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Chapter 2 
Materials and Methods 
2.1. Cell Culture 
The cells used in this study were rat hepatoma cell line (FG 14) originally obtained from a 
rat liver tumor by Mary Weiss and colleagues. These cells have been studied widely and 
genetically modified to allow for increasing our understanding of liver function. Cells were 
maintained in a medium containing I : I  Ham's F l2/Dulbecco's modified Eagle's medium (FDV) 
with 10% fetal bovine serum (FBS) plus 5 ug/ ml of penicillin and streptomycin (GIBCO). All 
cells were incubated in water-jacketed incubator at 37°C in a humid 5% C02. After two days, cells 
were split, counted cells by using a hemocytometer, and prepared for transfection. 
2.2. Cell Transf ection 
Cells were transfected with candidate genes through the process of lipofection using 
commercially available reagents (lnvitrogen). In this procedure, DNA is introduced into the cells 
using liposomes. The liposomes trap the DNA and fuse with the cell membrane of the target cells, 
releasing the DNA into the cells. Expression vectors containing candidate genes (PRRXI and 
SNAl2) purchased from Origene, Inc. were introduced separately into the rat hepatoma cell line 
(FG 14) by lipofection. 6-Well cell culture plates were used for the transfection of candidate genes. 
0.5 ml of FDV media without penicillin and streptomycin (Pen/Strep) was added to a 
microcentrifuge tube. DNA ( 1  µg/µl) along with 5 µl Lipofectarnine Plus reagent (lnvitrogen, Inc) 
was added and mixed gently for five minutes at room temperature. Then, 5 µl of Lipofectamine 
L TX reagent was added and mixed gently by pipetting and incubated for 30 min at room 
temperature. 
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Cells to be transfected were plated at a density of 1 06 /well in a 6-well format the day before 
transfection. Media on cell plates was removed by pipetting. The transfection mixture prepared in 
the microfuge tubes were added in the wells of the plates and incubated at 37° C in 5% C02 
incubator for 6 - 8 hrs, rocking periodically. After 6 - 8 hrs, medium was replaced with FDV 
containing 10% fetal bovine serum plus penicillin and streptomycin and incubated for 2 days at 
37° C in 5% C02 incubator. For stable transfection, cells were split into various dilutions (typically 
several replicate T-25 flasks at 1 :20, 1 :  1 0  and 1 :5 dilutions) in complete medium plus 500 µg /ml 
G418 and incubated for 2-3 weeks. After that, G418 resistant clones were pooled ( 1 0-50 clones 
per pool) or picked individually then expanded into larger plates until the cells could be lysed and 
RNA extracted. 
To monitor transfection efficiency, cells were also transfected with a Green Fluorescent 
Protein (GFP) expression plasmid. Typically, 4-6% transfection efficiency was achieved as 
determined by counting the number of GFP positive cells 48 hours post-transfection. In addition, 
a no-DNA control plate was used a negative control to ensure that no G418 -resistant cells were 
present in the cell line being transfected. 
2.3. RNA Extraction 
RNA was extracted from 70-80% confluent monolayers (approximately 1 07 cells) using a 
Qiagen RNeasy Mini Kit (Cat #74104) following the manufacturers protocol with the addition of 
a DNAse I (Cat #79254) digestion step, as per protocol. Briefly, nutrient medium was removed 
from the culture dish, and cells were lysed by treating with 350 ul highly denaturing guanidine 
isothiocyanate (GITC) containing RL T buffer and P-mercaptoethanol and mixed by rocking the 
plate, then scraped and transferred into a Qiashredder column in a 2 ml collection tube. Samples 
were centrifuged 2 minutes at 1 5,000 rpm to homogenize. The flow-through was mixed with 70% 
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ethanol by pipetting, the mixtures were transferred to RNeasy columns in collection tubes and 
centrifuged at I 0,000 rpm for 1 5  seconds and flow through discarded. 
Next, RWl buffer was used to wash the resin and centrifuged 1 0,000 rpm for 15  secs followed 
by digestion with DNase I in RDD buffer (Qiagen Cat #79254) for 1 5  minutes at room temperature. 
To prepare DNasel, 10 ul of DNAsel was added to 70ul RDD (supplied with DNaseI kit). Next, 
RWl buffer was applied to onto the RNeasy column and centrifuged 10.000rpm for 1 5  seconds. 
The RNeasy column was transferred to a new 2 ml collection tube, and the RNeasy column was 
washed twice with 500ul RPE and centrifuged after each wash. Finally, the RNeasy column was 
transferred to a 1 .5  ml tube, and the RNA was eluted by adding 40 µl RNase free water into the 
column and centrifuging at 14,000 rpm for one minute. The RNA samples were collected in 
microfuge tubes and stored at 70° C. A Bio line spectrophotometer with a nanodrop plate reader 
was used to determine the concentration and purity of the RNA. 
2.4. cDNA Synthesis 
Complementary DNA was obtained using the reverse transcriptase enzyme from a mature, 
fully spliced, messenger RNA. The mature RNA was purified from the cells using affinity 
chromatography (Ying, 2004). The complimentary DNA strand was then created by the addition 
of the poly-T oligonucleotides that anneal to the poly-A tails of the RNA. The second strand was 
generated by first digesting the RNA strand using RNase H followed by synthesis of the 
complementary strand to yield double stranded DNA. 
The MasterArnp High Fidelity RT-PCR kit {Applied Biosystems, part# 4368814) was 
used to generate cDNA from purified RNA. Reaction mixtures contained ( 1  OX RT Buffer, 25uM 
dNTP Mix, 1 OuM RT Random Primers, MultiScribe and sterile nuclease free water) and 1 =:J g  
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RNA in a final 20[1 µ1 volume. The RNA mixture was incubated at 37° C for 30 minutes. The Bio­
rad Thermal Cycler was used to synthesize cDNA using 25 °C for I 0 min, followed by 37° C for 
2 hours, 85°C for 5 min, then 4° C until reactions could to be transferred to a microfuge tube and 
stored at -20° C. The stored cDNA tubes were diluted to the appropriate concentrations used for 
quantitative PCR (qPCR). 
2.5. Primer Design 
Primer design was done using software provided by NCBI. This program has been optimized 
to identify primer pairs that hybridize to single gene targets at temperatures between 55 and 65 °C 
and produce short amplicons when using qPCR. Typically, the melting temperature of the primers 
can be calculated using nearest neighbor thermodynamic calculation. Specificity of the primers 
can be improved by ensuring the 3' ends are not very sticky. The intermolecular homology within 
the primers should be avoided to reduce the chances of the formation of the snap backs that 
interfere with the annealing process (Lin and Brown, 1992). 
In this study, the primers were ordered from Integrated DNA Technologies Inc. Three 
primers sets were designed for each gene to be tested, and the primer set that produced optimal 
amplification with lowest background signal for both the parental hepatoma cells and fibroblasts 
cells were used for further experiments. We monitored expression of several genes known to be 
important in hepatic and fibroblast function. Primer pairs used for this study as well as predicted 
melting and annealing temperatures are given in the Tables 3 and 4. 
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Table 3. Primers used in the quantitative Polymerase Chain Reaction (qPCR), primer sequences, 
melting temperature and annealing temperature of primers for the parental hepatoma cells. 
Annealing 
Primer Primer Sequence Tm temperature (0C) 
(OC) 
HNFl F- 5'CCA TICTGAAAGAGCTGGAGAAC 3 '  57.l 60 
R- 5'AGGTACGACTTGACCATCTITGC 3' 55.6 
rHNF3 (4) F- 5' TGGCAGAACTCCATCCGTCATTCT 3' 60.2 64 
R- 5' TCCTTCAACGCCAGTICGTTCTCA 3' 60.5 
HNF4 F- 5' TGAGCCTGGAGGATIACATCAAC 3' 56.6 60 
R- 5' AACTGGATCTGCTCGATCATCTG 3' 56.5 
HNF6 F-5' CAGTGGCTCTAAGCACAGTAA 3' 54.5 60 
R-5' CAGTGTGGTGGAACAGAT AAGA 3' 54.3 
SERPINAI F-5' CCTATACCGGGAGCTGGTCCAT 3' 60.3 64 
R-5' TTGCGAGTGTCACCCTTGCT 3' 59.5 
ALB F-5' CATCCTGAACCGTCTGTGTG 3' 55.7 60 
R-5' TITCCACCAAAGACCCACTA 3' 55.8 
rKNGl(I) F-5' AACACAATIGCCGCCTICTCACAG3' 60.2 64 
R-5' GTGCAATGGAATGACCAAGTGCCT 3 '  60.2 
rFGBI (4) F-5' AAGGAGACAAGGTGAAGGCACACT 3' 60.3 64 
R-5' AAGAACATGCCGITGTGGATGCTC 3' 59.9 
rPCKl (2) F- 5 '  CGCTATGCGGCCCTTCTTT 3' 58.3 60 
R-5' CGTGAAAGATCTIGGGCAACT 3' 57.5 
rgAPpJI F-5' TGATICTACCCACGGCAAGTT 3' 56.5 60 
R-5' TGATGGGTITCCCATTGATGA 3' 54.2 
rCREGl (3) F-5' CATCAGACACCCTGAGATGAAA 3' 54.4 60 
R-5' GGTCCACCAAAGTAGTCCAAA 3' 54.8 
Serpina3n F-5' ACT GGG AGA GGA CAC TCT A TT3' 54.5 60 
R-5' GTA GAG GCT GAA GGC AAA GT3' 54.7 
Serpina6 F-5' AAC CAG CAT GTC AAG GAT AAG A3' 54.1 60 
R-5' GCC TCT GAG GAA GAT GTA GTI G3' 54.8 
32 
Table 4. Primers used in the quantitative Polymerase Chain Reaction (qPCR), primer sequences, 
melting temperature and annealing temperature of primers for the parental fibroblasts cells. 
Annealing 
Primer Primer Sequence Tm temperature (°C) 
{°C) 
Mouse F- 5'TGT CTI TGA GCG GAC ACATIA 3' 54.2 60 
Prrxl R- 5'GAA CTI GGC TCT TCG GTICT 3 '  54.9 
Rat Prrxl F- 5'GAA CCG AAG CTG GGA GAAA 3 '  54.9 60 
R- 5'AGG AGA GAGAGAGAGAGAGAGA 3' 54.9 
SnalZ F- 5'CTG GAT ACT CCT CAT CTTIGGG 3' 54.5 60 
R- 5'CTCTICGTCACTAATGGGACTI 3' 54.l 
C-FQ.s F- 5'GCT GGT GCA TIACAGAGAGAA 3' 54.8 60 
R- 5'GTGTGTTTCACGCACAGATAAG 3 '  54.3 
Twist F- 5'TCG CTG AAC GAG GCA TIT 3' 54.8 60 
R- 5'GCC AGT TIG AGG GTC TGA AT 3 '  55.1 
Shox2 F- 5'CTG AAG GAT CGC AAA GAG GATG 3 '  55.6 60 
R- 5'CGT TGA GTI GTI CCA GGG TAAA 3' 55.2 
Sppl F- 5'CAG CCA AGG ACC AAC TAC AA 3' 55.0 60 
R- 5'TGC CAA ACT CAG CCA CTI 3' 54.8 
Bmpl F- S'CTA GAG OCT AGA GGG AGA ACIT 3' 54.9 60 
R- 5'GAC AGA GAG ACA GAG ACA GAGA 3' 54.8 
Coll al F- 5'ACT GGT ACA TCA GCC CAA AC 3' 55.0 60 
R- 5'GGA ACC TIC GCT TCC ATA CTC 3 '  55.3 
Sema3a F- 5'GGG ACG AGA CTI TGC TAT CTI C 3' 55.l 60 
R- 5'GATGGGCACTGATGAATCTAGG 3' 55.1 
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2.6. Quantitative-Polymerase Chain Reaction (qPCR) 
q-RT-PCR assays were performed in triplicate for each gene tested All the cDNA samples 
were diluted and concentration (5 ng/µl) was standardized among the samples. A final volume of 
20 µl ofreaction mixture contained 2 µl of specific cell line cDNA template (5 ng/µl), 2 µl of both 
forward and reverse gene-specific primers (0.5 µM) (IDTDNA), 6 µl of sterile nuclease free water, 
and I O  µl of Fast SYPR© Green Master Mix (Applied Biosystems), with the total volume of the 
reaction mixture at 20 ul. The list of primers used for genes and their Tm are described in Tables 
3 and 4. An Applied Biosystems StepOne qPCR machine was used to amplify cDNA. Typical 
reactions included 40 cycles, with the first step at 95° C for 3 min, followed by second step at 5° 
C above melting temperature (Tm) for the primers 30 min for extension/ annealing, and an 
extension step at 60° C for 60 min. Also, the control used in the RTqPCR experiments contained 
2 µl of gene specific primer (0.5 uM) (IDTDNA), 8 µl of sterile nuclease free water, and l 0 µl of 
Fast SYPR© Green Master Mix (Applied Biosystems), but were without target cDNA. 
The cDNA quality was tested against the reference gene GAPDH. Duplicate assay was 
performed for each cell line and the reaction was repeated three times. Raw threshold (Ct) value 
was averaged after the amplification for each cell line. The amplified target genes in each cell 
line were normalized to the respective GAPDH Ct-value, generating a delta-Ct value (Act). 
Fold differences in gene expression were determined with a delta delta-Ct (MCt) calculation. 
The L:lCt of the control cell line was subtracted from the test LlCt value, generating a Lll'.lCt value. 
Using a log base 2 scale, the calculated difference was placed into the LlllCt equation: 2(LlCt 
(sample -experimental) - (LlCt Control). Standard deviation (SD) and P-value of LlllCT in 
three biological replicates was calculated using a threshold to select significant transcriptional 
regulation edges. 
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2.7. Cell Migration Assay 
The scratch assay is an easy way to monitor cell migration in vitro. In this study we monitored 
cell migration of Prrxl and Sna2 transfected Fgl4 cells (Fgl 4-Prrx l & Fgl 4-Snai2) compared to 
the non-transfected cells (Fg14 hepatoma & RATl fibroblasts) (Hulkower and Herber, 201 1 ). In 
this technique, using a sterile 1 2  well plate. a marker was used to draw horizontal l ines at the 
base of the plate. One ml of culture cells containing - 1 06 cells were added to each of the wells 
and incubated for 24 hours at 37C that allowed to attach. spread. and form a confluent 
monolayer. The next day. a 200 J µl micropipette tip was used to scratch a trough in each well 
by dragging the pipette tip along the entire length of the well such that the scratch was 
perpendicular to horizontal line of the marker. 
The 1 2  well plate was then visualized using light microscopy connected to a computer 
installed with imaging software. Images were acquir�d at 0, 4,8, 1 2  hours and so on until the 
scratch was completely or nearly filled in. 
c 
Figure S. Images of Scratch Assay. A "wound" is introduced into a confluent mono layer of 
cells (A) by drawing a tip across the cell layer (B). The denuded area is imaged to measure the 
boundary of the wound at pre-migration (C) and after cells have migrated inward to fill the void 
(D). 
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2.8. Photomicrography of cells 
To monitor differences in cell morphology of the transfected and non-transfected Fgl4 
cells and RAT 1 fibroblasts, cells were plated onto coverslips placed in a 6 well plate and incubated 
overnight at 37°C in a 5% C02 incubator. The following day, forceps were used to remove 
coverslips containing the cells, and the coverslips were placed on a slide with cells facing the slide. 
PBS was added as needed to prevent drying of the cells the images were collected on 400x 
magnification using phase 2 rings. 
36 
Chapter 3 
Results 
As a model to understand the role of candidate genes Prrx 1 and Snai2 in regulation of 
fibroblasts-specific gene expression, the hepatoma cell line Fg14 was used. Previous results from 
our laboratory showed that these two genes, originally identified as candidate master regulatory 
genes in a genome-wide screening of gene expression in hepatoma x fibroblast cell hybrids (Bulla, 
2010), could remodel cell hybrids to become more fibroblastic in nature. The goal of this study 
was to determine whether these genes could drive expression of fibroblasts-lineage specific 
transcription factors (TFs) in a fully differentiated hepatoma cell line. 
To this end, expression plasmids containing Prrxl (paired related homeobox) and Snai2 
(snail family transcriptional repressor 2) genes in expression cassettes in a neo plasmid were 
transfected individually into the Fg14 cells and transfected cells obtained using G41 8  selection. 
G41 8  resistant clones were picked individually or pooled and expanded into l OOmm cell culture 
dishes. RNA was then extracted and used to generate complimentary DNA (cDNA) that was then 
used in the qPCR reactions to monitor expression of target genes. 
3.1. Prrxl overexpression in Fg14-transfected cells 
First, Prrx l gene expression was compared between the RATI fibroblasts cells and the 
Fgl4 cells using rat-specific primer. As shown in Figure 6, Prrxl gene expression is robust in the 
RA Tl  fibroblasts, but nearly undetectable in the Fgl 4 cells. We next asked whether the transfected 
mouse Prrx l gene was expressed in transfected Fg14 cells. To do this, mouse-specific primers 
were used, as the rat primers failed to cross-hybridize to the mouse cDNA sequences (results not 
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shown). qPCR analysis revealed that Pmd was successfully over-expressed in pooled Fgl4 
transfectants as well as individual clones compared to the non-transfected Fg14 cells (Figure 7). 
Prrxl is a fibroblast-specific gene 
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Figure 6. Prrxl is highly fibroblast specific. Rat specific primers were used monitor Prrx 1 
expression in the Fgl4 rat hepatoma and Ratl fibroblast cells by qPCR analysis. The fold 
activation was normalized to GAPDH levels using the ��CT method for each cell line. The 
experiments were repeated at least 3 times, with triplicate reactions set for each trial. 
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Both the pooled clones well as the 6 individual clones tested expressed the introduced Prrx 1 
gene at levels > 1 000 fold higher than the signal in the Fgl4 cells (Figure 7). Note that, because 
these are mouse-specific primers, background signals in the rat-derived Fg14 cells could either be 
due to cross-hybridization to rat sequences, or spurious hybridizations to other sequences resulting 
in background amplification. For this reason, cycle number differences compared to the parental 
Fg14 cells are shown. 
3.2. Prrxl Overexpression - Activation of downstream fibroblast-specific genes 
Next, we asked whether Prrx 1 overexpression in hepatoma cells (Fg 14) could affect expression 
of downstream fibroblasts genes. Pooled F g 14-Prrx l cells were tested for fibroblast- specific gene 
expression using qPCR. Results showed that Prrx l activates several fibroblast-specific genes. Of 
the 9 fibroblast-specific genes tested, several of these (Cfos, Coll a l ,  Shox2, Twist, and Bmp3) 
were activated in Fg14-Prrxl pooled cells (Figure 8). Levels of activation ranged from 4-7-fold 
for Twist, Shox2 and Bmp3 to 1 5-25-foJd for Col 1 a l  and C-Fos. Other genes (Spp l ,  Slug, SemA3 
and Sna2) were unaffected. 
To verify the effect of Prrxl overexpression on activation of fibroblast-specific genes, we next 
tested expression profiles for individual Fgl 4-Prrx l clones, focusing on genes that showed 
activation in the pooled transfectants. While C-Fos expression was found to be nearly 1 00-fold 
higher expressed in the RATl cells compared to Fg14 cells, the Fg14-Prrxl pool and clones 
showed variable activation, ranging from 4 to 52-fold (Figure 9). Similarly, while Col l a l  
expression was found to be > 1 000-fold higher expressed in the RA T l  cells compared to Fgl 4 cells 
(data not shown), the Fgl4-Prrx l pool and clones showed variable activation, ranging from 3 to 
1 5-fold (Figure 10). 
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Figure 7. mPrrxl overexpressioo in traosfected Fg14 rat hepatoma cells. Mouse-specific 
primers were used to monitor over-expression of the introduced mouse Prrxl gene in the Fg14 rat 
hepatoma cell line. Fgl4 cells were stably transfected with a mouse Prrxl expression plasmid, and 
G4 l 8-resistant clones pooled or selected individually. Prrx I expression of cDNA derived from 
isolated mRNA was monitored by qPCR analysis. The cycle numbers shown are compared to those 
obtained from the Fgl4 cells and normalized to GAPDH levels using the ��CT method for each 
cell line. The experiments were repeated at least 3 times, with triplicate reactions set for each trial. 
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Figure 8. Prrxl activates several fibroblast-specific gene expressions (Cfos, Collal,  Shox.2, 
Twist, and Bmp3) in Fg14 rat hepatoma cells. Pooled Fg14-Prrxl were tested for fibroblasts 
specific genes expression using qPCR of cDNA derived from Fgl4 cells. The fold activation was 
normalized to GAPDH levels using the ��CT method for each cell line.The experiments were 
repeated at least 3 times, with triplicate reactions set for each trial. 
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Figure 9. Prrxl strongly activates C-Fos expression in Fg14 rat hepatoma cells. Prrx 1 -
oversexpressing Fgl4 cells (pooled and individual clones) were tested for C-Fos expression using 
qPCR of cDNA derived from Fg14 cells. C-Fos expression was found to be nearly 1 00-fold higher 
expressed in the RATI cells compared to Fg14 cells. The fold activation was normalized to 
GAPDH levels using the 66CT method for each cell line. The experiments were repeated at least 
3 times, with triplicate reactions set for each trial. 
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Figure 10. Prrxl modestly activates Coital expression in Fg14 rat hepatoma cells. Prrx I -
oversexpressing Fg14 cells (pooled and individual clones) were tested for Col l a  I expression using 
qPCR of cDNA derived from Fgl4 cells. Coll a l  expression was found to be > 1000-fold higher 
expressed in the RA Tl cells compared to Fgl4 cells. The fold activation was normalized to 
GAPDH levels using the L1L1CT method for each cell line. The experiments were repeated at least 
3 times, with triplicate reactions set for each trial. 
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3.3. Snai2 overexpression in Fg14-transfected cells 
We next tested whether overexpression of a second fibroblast TF, Snai2 (aka Slug), could 
activate fibroblast-specific genes in the Fgl 4  hepatoma cells. A mouse Snai2 expression plasmid 
was transfected into the Fg14 cells and 0418-resistant clones expanded and tested. Using rat­
specific primers which cross-hybridized to mouse Snai2 cDNA sequences, qPCR analysis revealed 
that Snai2 was successfully over-expressed in pooled Fgl 4  transfectants as well as individual 
clones compared to the non-transfected F g 1 4  cells (Figure l I). Both the pooled clones as well as 
the 6 individual clones tested expressed the introduced Snai2 gene at levels >I  000 fold higher 
than the signal in the the Fgl4 cells, which is nearly undetectable. 
3.4. Snai2 Overexpression - Activation of downstream fibroblast-specific genes 
We next asked whether Snai2 overexpression in hepatoma cells (Fg14) could affect expression 
of downstream fibroblast genes. Pooled Fgl4-Snai2 cells were tested for fibroblast- specific gene 
expression using qPCR. Results showed that Snai2 activated several fibroblast-specific genes. Of 
the 8 fibroblast-specific genes tested, several of these (C-fos, Shox2, Twist, and Bmp3) were 
activated in Fg1 4-Snai2 pooled cells (Figure 12). Levels of activation ranged from 3-1 6-fold for 
(Twist, Shox2 and Bmp3) to 25-fold for C-fos. Other genes (Sppl ,  Prrx l ,  SemA3 and Col l a l )  
were unaffected. 
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Figure 1 1 .  Snai2 over-expression in the Fg14 rat hepatoma cell line. Fg14 cells were stably 
transfected with a mouse Snai2 expression plasmid, and G41 8-resistant clones pooled or selected 
individually. Snai2 expression of cDNA derived from isolated mRNA was monitored by qPCR 
analysis. The cycle # was normalized to GAPDH levels using the L\L\CT method for each cell 
line. The experiments were repeated at least 3 times, with triplicate reactions set for each trial. 
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Figure 12. Snai2 activates additional fibroblasts specific genes (Cfos, Twist, Shox2, and 
Bmp3) expression in Fg14 rat hepatoma cells. Pooled Snai2-expressing Fg14 and clones (Fg14-
Snai2-Pooled) were tested for fibroblasts specific gene expression using qPCR of cDNA derived 
from extracted RNA. The fold activation was normalized to GAPDH levels using the ��CT 
method for each cell line. The experiments were repeated at least 3 times, with triplicate reactions 
set for each trial. 
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To verify the effect ofSnai2 overexpression on activation of fibroblast-specific genes, we next 
tested expression profiles for individual Fg1 4-Snai2 clones, focusing on genes that showed 
activation in the pooled transfectants. While C-Fos expression was found to be nearly I 00-fold 
higher expressed in the RATl cells compared to Fg14 cells, the Fg14-Snai2 pool and clones 
showed variable activation, ranging from 9 to 70-fold (Figure 1 3  ). Likewise, Twist expression was 
found to be > 1000-fold higher expressed in the RA Tl  cells compared to Fgl 4 cells (data not 
shown), but the Fgl 4-Snai2 pool and clones showed variable activation, ranging from 16 to 90-
fold activation (Figure 14). 
While Shox2 expression was found to be > 1 000-fold higher in the RA Tl cells compared 
to Fg14 cells (data not shown), the Fg1 4-Snai2 pool and clones showed variable activation, ranging 
from 3 to 7-fold (Figure 1 5). Bmp3 expression was found to be >1 000-fold higher in the RATI 
cells compared to Fg14 cells (data not shown), the Fg14-Snai2 pool and clones showed variable 
activation, ranging from 1 to 5.5-fold (Figure 16). 
3.5. Effect of Snai2 and Prrxl overexpression on hepatoma gene expression 
Based on the above findings, we hypothesized that overexpression of fibroblast-specific 
transcription factor Pmd and Snai2 would result in partial loss of the hepatoma phenotype. We 
therefore monitored expression of a panel of liver -specific genes using qPCR analysis. First, we 
asked whether the transfected mouse Pmd in hepatoma cells (Fg14) could affect liver-specific 
genes. Pooled Fg14-Prrxlcells were tested for liver- specific gene expression using qPCR. To 
ensure that our primer sets could detect differences in expression levels, we tested cDNAs derived 
from Fgl4 hepatoma cells and the RATI fibroblasts. All genes tested showed >1 000-fold higher 
expression in the Fgl4 cells compared to the RATl fibroblasts (results not shown). 
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Figure 13. Snai2 strongly activates Cfos expression in Fg41-Snai2 clones. Fgl4-Snai2 pooled 
and clones were tested for Cfos expression using qPCR of cDNA derived from extracted RNA. C-
Fos expression was found to be nearly l 00-fold higher expressed in the RA T l  cells compared to 
Fg14 cells. The fold activation was normalized to GAPDH levels using the 66CT method for each 
cell line. The experiments were repeated at least 3 times, with triplicate reactions set each trial. 
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Snai2 over- expression activates Twist 
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Figure 14. Snai2 strongly activates Twist expression in Fg14-Snai2 clones. Fg14-Snai2 pooled 
and clones were tested for Twist expression using qPCR of cDNA derived from extracted RNA. 
Twist expression was found to be >1 000-fold higher expressed in the RATI cells compared to 
Fgl4 cells. The fold activation was normalized to GAPDH levels using the 66CT method for each 
cell line. The experiments were repeated at least 3 times, with triplicate reactions set for each trial. 
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Figure 15. Snai2 modest activates Shox2 expression in Fg41-Snai2 clones. Fg1 4-Snai2 pooled 
and clones were tested for Shox2 expression using qPCR of cDNA derived from extracted 
RNA.Shox2 expression was found to be 1 000-fold higher expressed in the RA Tl cells compared 
to Fg14 cells. The fold activation was normalized to GAPDH levels using the ��CT method for 
each cell line. The experiments were repeated at least 3 times, with triplicate reactions set for each 
trial. 
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Figure 16. Snai2 modest activates Bmp3 expression in Fg41-Snai2 clones. Fg14-Snai2 pooled 
and clones were tested for Bmp3 expression using qPCR of cDNA derived from extracted 
RNA.Bmp3 expression was found to be > 1 000-fold higher expressed in the RA Tl cells compared 
to Fgl4 cells. The fold activation was normalized to GAPDH levels using the 66CT method for 
each cell line. The experiments were repeated at least 3 times, with triplicate reactions set for each 
trial. 
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Of the 1 1  liver-specific genes tested, several of these (Cregl ,  Pck l ,  Hnf4, Serpina6, Hnf6, 
Serpina3n, Fgb4, Serpinal ,  and Kng l )  were repressed in Fgl4-Prrxl pooled cells compared to the 
parental Fg14 cells (Figure 17). Levels of repression ranged from 40 to 200-fold for Hnf4, Pck l ,  
Serpina6, Hnf6, and Serpina3n, to 7 to 23-fold for Creg l ,  Fgb4, SerpinaAl ,  and Kng l .  Other genes 
(Alb and Hnfl )  were unaffected. 
To verify the effect of Prrxl overexpression on repression of liver-specific genes, we next 
tested repression profiles for individual Fg14-Prrxl clones, focusing on genes that showed 
repression in the pooled transfectants. The Fg14-Prrxl pool and clones showed strong repression 
of Serpinal ,  ranging from 40 to 1 34-fold (Figure 1 8) .  Similarly, other hepatoma genes showed 
strong repression, including Hnf6 (20 to 3 1 4-fold), Serpina3n (34 to 1 42-fold), Serpina6 (64 to 90-
fold), and Hnf4 (75 to 246-fold) (Figure 1 8) .  Expression of other hepatoma genes were also found 
to be repressed in the Fg14-Prrxl clones. Repressed genes included Fgb (20 to 27-fold), Kng (34 
to 7 1 -fold), Pckl (26 to 34-fold), and Cregl (3.5 to 4.5-fold) (Figure 19). 
We next asked whether the transfected mouse Snai2 in hepatoma cells (Fgl4)  could affect 
liver-specific genes. Pooled Fgl 4-Snai2 cells were tested for liver-specific gene expression using 
qPCR. Results showed that Snai2 repressed several liver-specific genes. Of the 1 1  liver-specific 
genes tested, several of these (Alb, Pck l ,  Hnf4, Serpina6, Hnf6, Serpina3n, Fgb4, SerpinaAl ,  and 
Kng l )  were repressed in Fg1 4-Snai2 pooled cells. (Figure 20). Levels of repression ranged from 
29.5-163.5-fold for (Hnf4, Serpina6, Kngl and Serpina3n) to 5.5-14-fold for (Pckl ,  Hnf6, Alb, 
Fgb4, SerpinaAl ). Other genes (Cregl and Hnfl ) were unaffected. 
To verify the effect of Snai2 overexpression on repression of liver-specific genes, we next 
tested repression profiles for individual Fg1 4-Snai2 clones, focusing on genes that showed 
repression in the pooled transfectants. The Fg14-Snai2 pool and clones in Serpina6 showed 
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variable repression, ranging from 85 to 89-fold (Figure 2 1 ). Likewise, Kngl (4 to 22-fold), Hnf6 
(8 to 1 4-fold, Serpina3n (9 to 14-fold) and Hnf4 (9 to12-fold) showed repression, although at more 
modest levels. Finally, three liver-specific genes tested (Pck l ,  Alb, and Fgb4) showed repression 
ranging from 2 to 5-fold (Figure 2 1 ). 
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Figure 17. Repression of liver-specific genes in Prrxl transfected pooled clones (Fg14-prrxl 
pool) in the Fg14 hepatoma cell line. RNA levels of indicated genes were determined by RT-
qPCR and compared to levels in non-transfected Fg14 hepatoma cells. The fold repression was 
normalized to GAPDH levels using the L\L\CT method for each cell line. The experiments were 
repeated at least 3 times, with triplicate reactions set for each trial. 
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Effect of Prrxl on repression of liver-specific genes in 
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Figure 18. Fold repression of liver-specific genes (Hnf4, Hnf6, Serpina3n, SerpinaAl, and 
Serpina6) were affected strongly by Prrxl (pooled and individual clones) in the Fg14 
hepatoma cell line compered to non-transfected Fg14 hepatoma cells line as determined by 
RT-qPCR. The fold repression was normalized to GAPDH levels using the L\L\CT method for 
each cell line. The experiments were repeated at least 3 times, with triplicate reactions set for each 
trial. 
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Figure 19. Fold repression of liver-specific genes (Fgb4, Kngl, and Pckl) were affected 
strongly by Prrxl (pooled and individual clones) in the Fg14 hepatoma cell line as well as 
(Cregl) was affected lower by Prrx l .  Both were compered to non-transfected Fgl4 hepatoma 
cells line as determined by RT-qPCR. The fold repression was normalized to GAPDH levels using 
the !1!1CT method for each cell line. The experiments were repeated at least 3 times, with triplicate 
reactions set for each trial. 
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Figure 20. Repression of liver-specific genes in Snail transfected pooled clones (Fg14-snai2 
pool) in the Fg14 hepatoma cell line. RNA levels of indicated genes were determined by RT-
qPCR and compared to levels in non-transfected Fgl4 hepatoma cells. The fold repression was 
normalized to GAPDH levels using the ��CT method for each cell line. The experiments were 
repeated at least 3 times, with triplicate reactions set for each trial. 
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Figure 21.  Fold repression of liver- specific genes (Hnf6, Serpina3n, Serpina6, andHnf4) were 
affected strongly by Snai2 (pooled and individual clones) in the Fg14 hepatoma cell line as 
welJ as (Kngl , Pckl, Alb, and Fgb4) were affected moderate by Snai2 (pooled and individual 
clones) in the Fg14 hepatoma cell line. Both were compered to non-transfected Fg14 hepatoma 
cells as determined by RT-qPCR. The fold repression was normalized to GAPDH levels using the 
��CT method for each cell line. The experiments were repeated at least 3 times, with triplicate 
reactions set for each trial. 
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3.6. CeU Migration Assay (scratch method) and Morphology 
Migration is a key property of live cells and is critical for normal development, immune 
response, and disease processes. The process of migration assay occurs in most cells, but it is 
considered a hallmark assay for the fibroblasts. Based on these results, we sought to examine the 
migration of both Prrx I and Snai2 in affecting the phenotype of hepatocytes. We asked whether 
Snai2 and Prrx 1 overexpression in hepatoma cells (F g 14) could affect migration of transfected 
Fg14 cells compared to the parental ofFg14 and RATI cells. 
In this technique, using a sterile 1 2  well plate, a marker was used and draw horizontal lines 
at the base of the plate. Culture cells were added to each of the wells incubated for 24 hours at 37C 
to allow cells to attach, spread, and form a confluent monolayer. Next, a 200-microliter pipette tip 
was used to dislodge cells along the entire length of the well such that the scratch was 
perpendicular to horizontal line of the marker. Plates were then visualized by microscopy and 
images captured using imaging software. Images were acquired at several time points ( 4,8, 12, and 
1 6  hrs.) or until the scratch was completely or nearly completely filled in. We used this cell 
migration to differentiate migration behavior between hepatoma (Fgl 4), fibroblasts (RA T l ), 
Fg14-Snai2 clone 6 and Fgl 4-Prrxl clone 6. Results show that the Prrxl or Snai2 transfected cells 
had enhanced migratory capabilities of transfected cells compared to the parental Fgl4 cells 
(Figure 22 and 23). 
Next, we asked whether the cell morphology of the transfected hepatoma cells was altered. 
We compared the morphology of two of the clones, (Fgl 4-Prrxl clone 6 and Fg14-Snai2 clone 6) 
58 
to the parental Fgl4 cells as well as to the RA T2 fibroblasts cells. Results show that the transfected 
hepatoma cells have a morphology more consistent with that of the fibroblasts than the hepatoma 
parental cells (Figure 24). 
Taken together, our results show that overexpression of fibroblast-specific TFs Snai2 and 
Prrxl have the ability to reprogram the hepatoma cells to a fibroblasts phenotype that includes 
activation of expression of fibroblast genes and repression hepatoma gene expression (see 
summary in Figure 20), resulting in a change to a fibroblast cell morphology. 
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Figure 22. Cell Migration Assay (The scratch method). Difference in cell migration capabilities 
in hepatoma (Fg1 4), fibroblasts (RATl), Fg14- Snai2 clone 6 and Fg14-Prrxl clone 6 
overexpressed in hepatoma Fgl 4. Resulting have enhanced migratory capabilities of transfected 
cells (Prrxl or Snai2) compared to the parental cells (Fgl4 and RAT l ). 
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Figure 23. Difference in cell migration capabilities in hepatoma (Fg14), fibroblast 
(RATl), Fg14- Snai2Cl6 and Fg14-PrrxlCl6 overexpressed clones in hepatoma 
cells. The graph determines, the distance of the cells migration that were calculated by 
the ruler using Centimeter (cm) 
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Figure 24. Morphology changes due to Snail or Prrxl overexpression in hepatoma cells line 
Fg14. Comparison of cell morphology between parental cells (Fg l 4  hepatoma cells and rat 
fibroblast cells RAT-1)  with (Fg14- Pmd -clone 6 and Fgl4-Snai2-clone 6). Pmd and Snai2 
overexpressed clones produced a spindle-shaped morphology which more closely resembled the 
fibroblast cells. 
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Figure 25. Summary of fibroblast gene activation and liver gene repression observed in the 
Fg14 hepatoma cells transfected with Prrxl and Snail TFs. 
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Chapter 4 
Discussion 
In mammalian cells, transcription factors (TFs) play a maJor role in activation and 
repression of genes within a genome to regulate development. Gene expression in fibroblast cells 
is regulated by multiple control mechanisms including histone modification, chromatin regulation, 
transcriptional control, post-transcriptional regulation and cell-cell contact (Panduro et al, 1 987). 
Initiation of transcriptional activity requires promoter-proximal elements and enhancers (Lodish 
et al, 2000) to which transcription factors bind. As with all distinct tissues in complex organisms, 
fibroblast-lineage TFs bind to regulatory regions of certain genes in a synergistic fashion resulting 
in activation of genes that dictate fibroblast identity. 
Fibroblast-specific gene expression has been recently studied in this laboratory using cell 
hybrids as a model system combined with whole genome microarrays. The strategy to identify 
these genes was to compare whole genome transcriptome microarray data of hepatoma cells and 
hepatoma x fibroblast hybrid cells with that of parental fibroblast cells, based on their fold 
differences in expression. These experiments identified potential master regulators of fibroblast 
cell fate (fibroblast-specific TFs), and their putative regulatory role in fibroblast differentiation. 
Genes identified included transcription factors (e.g. Prrx 1/Pmx, Slug, Snai2, Shox2, CFOS, Twistl, 
Hox-dl O, and Msxl) as well as fibroblast-specific downstream such as Sema3a, (cell signaling) 
Sppl, Bmp3 (cell differentiation), and Collal (structural organization). 
Among the fibroblast-specific candidate genes identified that have putative roles in the 
maintenance of the fibroblast phenotype were transcription factors Prrxl and Snai2, which were 
used for further analysis of tissue-specific gene expression in fibroblasts. These genes were highly 
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expressed in fibroblasts, silent in hepatoma cells, and repressed in hepatoma x fibroblasts ce!J 
hybrids. Forced over-expression of these genes in the hybrid cells resulted in activation of 
fibroblast gene expression and resulting fibroblast-like morphology. Based on these results 
(described in the results section), we examined the role of Prrxl and Snai2 in affecting the 
phenotype ofliver-derived cells using hepatoma cells (Fgl4) as a model system. The rat hepatoma 
cell model in the current study has been used for over 50 years. The goal of this study was to 
determine the ability of fibroblast-lineage specific Tfs to remodel hepatoma cells. 
A master regulatory gene is one which is at or near the top of a regulatory "hierarchy" and 
as such can have a strong influence in driving the cellular networks responsible for cellular identity. 
A majority of the genes considered master regulatory genes encode transcription factors which 
then activate many downstream tissue-specific genes. However, the concept of a master regulatory 
gene has been criticized for being an oversimplified paradigm which does not take into account 
multifactorial influence on a number of cell fates. Our study focused on the role of Prrxl and Snai2 
as master regulators of fibroblast identity. 
Paired related homeobox 1 (PRR.Xl), also termed PMX l ,  PR.XI ,  and PRX-1, is a protein 
which is a member of a family of paired homeobox proteins confined to the nucleus. This protein 
has been shown to act by enhancing the binding of serum response factor to DNA, thereby 
indicating PRR.Xl functioning as a transcriptional coactivator. PRR.Xl also plays a role in the 
formation of various mesodermal muscle types through its role in the activating expression of the 
muscle creatine kinase (MCK) gene by binding to a Aff-rich element in the MCK gene enhancer. 
The expression of PRRXl is broadly expressed in fat (RP.KM 27.9), endometrium (RPKM 34.6), 
gallbladder, heart, and 1 5  other tissues (National Center for Biotechnology Information, 2018). 
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PRRXl has also been known to play a role in the epithelial to mesenchymal transition 
during development (Saika et al., 2007), as well as in regulation of mesenchymal cell fate, 
including myogenesis, osteoblastogenesis, and chondrogenesis (Lu et al. 201 1 ,  Martin et al. 
1995). Moreover, the PRRXI family of TFs are connected with other transcription factors and 
signaling proteins in cascades leading to gene regulation during fibroblast differentiation. Chen et 
al. (1993) reported that the target of many of these transcription factors appears to be the 
osteopontin gene, which encodes a matrix structural protein that serves as a component of bone 
matrix as well as serving as a marker gene for fibroblast identity. 
SNAI2 (Snail Family Transcriptional Repressor 2, also termed SLUG) is a member of the 
Snail family of zinc finger transcriptional regulators in mammals (Mistry et al, 2014). Studies 
suggests that SNAI2 is a TF that regulates gene expression during the epithelial-mesenchymal 
transition (EMT) and plays a very significant role in cell migration during tumor invasion or 
development (Mistry et al. 2014). SNAI2 has a vital role during embryogenesis and in adult tissues 
to maintain the normal functioning of the cells after birth. 
The significance of SNAl2 in cell migration is in its ability to downregulate the expression 
of E-cadherin resulting in highly structured epithelial cells to transitioning to a mesenchymal 
phenotype. This process significantly leads to gastrulation of mesoderm in which the single layered 
blastula is reorganized into a multilayered gastrula (Moly et al,.2016). SNAI2 also regulates 
epidermal progenitor cells which, together with fibroblasts, support adult skin homeostasis. 
Mutations within the SNAI2 gene are related to sporadic cases of neural tube defects which are 
associated with an anti-apoptotic activity. SNAl2 expression is ubiquitous in the endometriu� 
ovary and other 22 tissues in humans (National Center for Biotechnology Information, 2018). The 
Snail superfamily of zinc-finger transcription factors have also been implicated in the signaling 
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cascade that dictates left=right identity, as well as in the formation of appendages, neural 
differentiation, cell division and cell survival (Nieto, 2002). 
4.1. Reprogramming the gene expression profile of bepatoma cells by Prrxl and Snai2 
overexpression 
Results of the current study suggest that overexpression of Prrx 1 and Snai2 genes via 
introduction of an expression plasmids into the Fgl 4 hepatoma cells results in activation of 
fibroblast-specific TFs as well as downstream fibroblasts-specific genes. Although not studied in 
here, overexpression of PRRX 1 and SNAI2 in the hepatoma cell line likely also activated other 
fibroblast-specific TFs that work in collaboration with other TFs to define the drive lineage­
specific transcriptional regulatory circuitry. 
We first verified previous results showing that both PRRXI and SNAI2 are expressed at 
levels > 1 000-fold higher than those in the hepatorna cells (Figs 7 and 1 1). We were able achieve 
high level expression of both mouse PRRXl and mouse SNAI2 in the rat hepatoma cells using 
expression vectors from Origene which used a cytomegalovirus promoter/enhancer to drive 
expression of the target genes (Du et al., 2012). It should be noted that while the rat primer sets 
used to monitor expression of the Snai2 gene detected both rat and mouse transcripts, the mouse 
Prrx 1 primers failed to hybridize to the rat Prrx 1 sequences. However, the results did show strong 
expression of mouse Prrx 1 gene in the cells compared to non-transfected cells, both in the pooled 
transfectants and the individual clones analyzed (Figs 6 and 7). 
Importantly, over-expression of the mouse Prrxl gene in the hepatoma cell line resulted in 
activation of several fibroblast-specific TFs and downstream genes, including Shox2, Bmp3, c­
Fos, and Twist. Likewise, overexpression of Snai2 in hepatoma cell line activated many of the 
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same genes (Shox2, Bmp3, c-Fos, and Twist). This data was supported by monitoring expression 
in several individual clones, which largely reflected data from the pooled transfectants (Figs.8 and 
12) and (Figs. 9,10,13,14,15, and 16) 
These data suggest that PR.RX 1 and SNAI2 act in a similar fibroblast regulatory network. 
However, the overlap was not complete: The Collal gene, a common marker for fibroblast 
identity, was strongly activated ( 1 5-fold) by Pmd (Fig 10), but no detectable activation was 
observed in the Snai2-trranfected cells (Fig 12). It was surprising that while both these genes 
independently activated a similar set of genes, neither SNAI2 nor PRRXl overexpression activated 
expression of the other gene. This suggests that they TFs feed into the same regulatory pathway, 
but at different points in the pathway 
Our results show that Twist is markedly upregulated by both overexpression of Prrxl and 
Snai2 in the hepatoma cell line. Twist is a member of a family of basic helix-loop-helix 
transcription factors and a known mediator of mesodermal tissue development (lsenmann 
et.al,.2009). It also has been reported to play an essential role in various stages of embryonic 
development (Ning et al, 2018). 
Interestingly, several TFs have been identified as master regulators of the Epithelial­
mesenchymal transition (EMT) program, including TWIST I ,  Snail family zinc finger 1 (SNAIL 1 ), 
Zinc finger E-box-binding homeobox (ZEB), PRRX l ,  KLF4, SOX4, and SOX9 (Zhou et al, 2017), 
suggesting correlation between Snai2, Prrx l ,  and Twist in the pathways of EMT. During EMT in 
humans, SNAIL2 replaces SNAIL l  to make drive TWISTl expression, on the human SNAIL2 
promoter activating its transcription by TWISTl specifically binds to the E-box (Casas et 
al,.201 1 ). Through early embryogenesis, TWISTl and SNAIL2 are also functionally connected 
(Martin et al, 2005). Our data support a direct correlation between TWIST and SNAIL2, an 
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interaction which has been reported to be conserved functionally through embryogenesis and 
tumor metastasis. 
C-Fos was also found to be significantly upregulated by individual overexpression of 
Prrxl and Snai2 genes in hepatoma cell line. C-FOS is a transcription factor with a leucine zipper 
motif that heterodimerizes with members of the Jun family to form the Activator Protein (AP-I) 
TF. Prrx l has previously been shown to take part in the activation of CFOS/c-JUN complex of 
AP-1 that has an important role to drive the transcriptional activation of osteopontin gene and other 
osteoblastic markers (Nakamachi et al,.2007, Ohta et al.1991). PRRXl has a regulatory role on 
the CFos gene, and the heterocomplex of cFOS and cJUN is linked with osteoblast proliferation 
(Okazaki et al,. 1 992). Bai et al, (2006) suggests that PRRXI is associated with CFOS. 
Additionally, abnormal expression of SNAl2 and C-FOS has been linked to obesity that can 
increase the risk of female reproductive tract cancers (Yang et al, 2012). 
Both Shox2 and Bmp3 genes were found to be upregulated by overexpression of Prrxl and 
Snai2 genes in the hepatoma cell line. SHOX2 (short stature homeobox 2) is a member of the 
homeobox family of transcription factors. The growth and development of the vertebrate limb 
depend on homeobox genes of the Hox and Shox families (Neufeld et al. 2014). SHOX2 also plays 
an important element in the osteoblast differentiation (Gu et al.2008) and SHOX2 and PRRXl are 
both connected with osteopontin gene regulation. BMP2A and BMP3 (known as Bone 
morphogenetic proteins) are TFs that play an important role in fibroblast differentiation and in 
mesenchyme stem cell differentiation into multipotent osteoblastic, myogenic, adipogenic, 
chondrogenic cells (Matsubara et al. 2008) 
Interestingly, Col la !  was upregulated by overexpression of Prrxl, but not Snai2, in the 
hepatoma cell line. The Col la l  gene encodes type I collagen, which is the most abundant form of 
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collagen that strengthens and supports many tissues in the body such as cartilage, bone, tendon, 
ligaments, the dennal layer of skin, and the sclera of the eye. A study by Palumbo et al, (2017) 
suggests a correlation between Twist and Col l a l  expression in skin fibrosis. Matsushita et al. 
(2009) reported that ERK.I and ERK2 regulate osteoblast differentiation and bone fonnation 
through multiple regulator genes including Prrxl ,  RunX2, Cfos, Shox2, Bmp3, Twist). Based on 
the infonnation above, fibroblasts and osteoblasts may have common precursor cells, 
mesenchymal stem cells, which may indicate that, during bone development, fibroblasts might be 
the precursor of bone cells (Shrestha, 201 1 ) .  
Previous studies from our lab showed that overexpression of Prrx 1 in hepatoma x fibroblast 
hybrids was able to strongly activate the Snai2 gene. Likewise, Snai2 overexpression activated the 
Prrxl gene in these cell hybrids (Ray. 2016) However, results presented in the current study 
showed that neither gene could activate the other. This suggests that the hybrid cells are more 
flexible regarding reprogramming than are the hepatoma cells. 
Because the above results suggest that several genes involved in fibroblast identity and 
function could be activated by the introduction of a single transgene, we hypothesized that 
overexpression of fibroblast-specific transcription factors Prrxl or Snai2 would also result in a 
partial loss of the hepatoma phenotype. We therefore monitored expression of a panel ofhepatoma­
specific genes (both those encoding transcription factors and downstream genes) including (Cregl ,  
Pckl ,  Hnf4, Serpina6, Hnf6, Serpina3n, Fgb4, SerpinaAl ,  Alb, Hnfl and Kngl) using qRT-PCR 
analysis, Results show that, in the Prrx 1 -trasnfected pooled clones, 9 of the 1 1  liver-specific genes 
tested were repressed at levels ranging from 3 fold (Cregl )  to 200-fold (Serpin A6). This effect 
was verified by monitoring repression of several of these genes in individual transfected clones, 
with results generally similar to those found in the pooled clones (Fig. 1 7, 1 8  and 19). 
71 
Likewise, the pooled Snai2 transfectants as well as individual Snai2-expressing clones 
were found to repress expression of mostly the same liver genes as those in the Prrx I transfected 
cells, with levels of repression being similar (Figs 20 and 2 1  ) .  
4.2. Reprogramming of morphology and migratory properties of hepatoma cells by Prrxl 
and Snail 
In addition to Prrx 1 and Snai2 having a strong effect on gene expression profiles in the 
hepatoma cells, our results also suggest that both Prrxl and Snai2 contributed to reprograming of 
hepatoma cells to a more fibroblast-like phenotype in two ways. First, we observed restoration of 
the fibroblast phenotype as shown by their acquisition of a more spindle shaped morphology in 
contrast to that of the hepatoma cell (Fig 24). Second, we observed the transfected hepatoma cells 
have an increased migratory ability compared to the parental cells that became more pronounced 
at the 1 2  and 1 6-hour times points (Fig 22and 23). 
As ctiscussed above, cell migration is a very important cellular process for the normal 
development of tissues and organs. Fibroblast are able to migrate within tissues through the 
formation of lamellipodia. The migration of fibroblast relies on the initiation of focal adhesion 
kinase (F AK) and a corresponding interaction with tenascin-C (McKean et al., 2003). 
Experiments using F AK-null embryos suggest that F AK affects embryogenesis by both controlling 
cell proliferation as well as cellular morphology and migration. An increase in cell spreading and 
migration on fibronectin is made possible by the stable stimulation of f AK (McKean et al. 2003) 
provide a different possibility that F AK stimulates the expression of extracellular matrix genes and 
proteins which are significant in creating migratory tissues environment even though the idea has 
not been fully established. 
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It has been recently shown in our lab by Ray (2016) using a chemotaxis-based cell 
migration assay to distinguish the migratory behavior between hepatoma, fibroblasts, and 
hepatoma fibroblast hybrid, that SNAI2 or PRRXl overexpression in cell hybrids resulted in a 
partial reversion back their fibroblast phenotype. The results further showed that hybrids which 
exhibited forced overexpression of both SNAI2 and PRRXl by- > I O-fold show increased 
migration abilities when compared to the non-transfected hybrid. 
According to Hulkower and Herber (201 1), cell migration and invasion assays are critical 
for drug discovery to understand the correlation between compounds that inhibit migration and 
invasion in vitro. Our observations establish that Prrxl and Snai2 overexpressed in hepatoma cells 
(pools and individual clones) show enhanced the cell migration behavior (Fig. 22). 
4.3. SNAU and PRRXl in Diseases 
Based on our results and other studies, Prrxl and Snai2 independently show the ability 
activate pathways that contribute to the fibroblast phenotype and possibly to direct disease 
progression. We observed cross talk between fibroblast lineage specific (Prrxl and Snai2) and 
downstream genes, including (e.g. C-fos, Twist, Shox2, Bmp3). Accordingly, Jiang and Pugh 
(2009) showed that both Prrx I and Snai2 functions are connected with super enhancers in several 
fibroblast cell types. Thus, we have identified Snai2 and Prrx I as strong fibroblast lineage specific 
candidate TFs that appear to play an essential role in determining and maintaining fibroblast cell 
fate. 
Interestingly, about 10% of the transcription factors have a significant relationship in a very 
large number of human diseases (Bouhlel et al. 201 5) The TFs that control pathways are important 
to decipher because they have the potential to define cell identity, enhance cellular reprogramming 
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for regenerative medicine, and improve our understanding of an abnormal transcription factors 
leading to disease (Saint et al. 2016). 
Several studies have been reported that deregulation or upregulation of either Prrx 1 and 
Snai2 lead to cancers in different tissues of fibroblasts (Hirata et al,.2014, Moreno-Bueno et al 
2008) such as SNAI2 has been reported to regulate cell proliferation and invasiveness of metastatic 
prostate cancer cell lines (Baygi et al.2010). Several other studies have likewise suggested the 
importance of SNAI2 in cancer development (Wang et al. 201 1 ;  Buehler et al. 201 2), Likewise, 
downregulation of PRRXI via the p53-dependent signaling pathway predicts poor prognosis in 
hepatocellular carcinoma (Fan et al. 20 1 7). Furthermore, metastatic colonization has been reported 
to require the repression of PRR.Xl (Ocana et al. 2012). 
4.4. SNAU and PRRXl Knockout Mice 
ln Snai2 knockout mice revealed alterations in epidermal differentiation, adhesion, 
motility, and angiogenesis although genes that are direct targets of SNAI2 remain unknown and 
that wound healing is impaired =in SNAI2 knockout mice (Mistry et al. 2014, Hudsonet al, 2009) 
This finding is used to support the claim that SNAI2 expression is augmented in epidermal cells 
neighboring a wound consequently supporting epithelial-mesenchymal transition to permit 
relocation to the injury hence stimulating re-epithelization (Mistry et al., 2014). 
In Prrx 1 with knockout mice, it was reported that tumor weights and volume were greater 
Conversely, research by Du et al. (201 1 )  suggested that Prrx l knockdown decreases transforming 
growth factor-P (TGFP) ligand expression and increases adipogenesis, whereas Prrx l rises in 
adipose tissue through obesity. Therefore, Prrx l knockdown enhanced adipogenesis by 
suppressing TGFP signaling. 
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Thus, evidence suggests that Prrx 1 and Snai2 are necessary to program and maintain 
fibroblast function. The results of this study suggest that the factors individually have the ability 
to reprogram a fully differentiated cell type into the fibroblast linage and extend the results of Ray 
et al who reported the reprograming of hepatoma x fibroblast hybrids by these TFs. 
4.5. Conclusions. 
We were able to show that candidate master regulator genes Prrx 1 and Snai2 have a 
remarkable ability to reprogram a fully differentiated hepatoma cell line into a cell type with a 
partial fibroblast phenotype. We showed activation of several key genes encoding fibroblast­
specific transfection factors (as well as and downstream genes) combined with strong repression 
of several liver-specific genes. Furthermore, these results suggest that both cellular morphology 
and migratory abilities can be altered by the liver-expression of either of these transcription factors. 
This study also provides a proof-of-concept that master regulatory genes can be idenlified 
by comparing expression profiles of fibroblast with cell lines of other cell types. In our case, we 
compared profiles of fibroblasts with those of hepatoma and hepatoma x fibroblast hybrids. The 
inclusion of the cell hybrids in the analysis allowed identification of some genes that may not have 
been identified using comparisons of expression profiles of only fibroblasts and hepatoma cells. 
Importantly, the inclusion of cell hybrids allowed us to exclude a large number of candidate genes, 
as we required a >5-fold increase in expression of a gene in fibroblast compared to both hepatoma 
and hybrid cells. 
This result of this study supports the idea that single TFs can direct tissue identity through 
activation of transcriptional regulatory networks that both drive some linage specific genes as well 
as repress others. These results also demonstrate that fully differentiated cell types (e.g., hepatoma 
75 
cells) can be reprogrammed in a straight-forward way by overexpression of key transcription 
factors (e.g. Pmd or Snai2). 
4.6. Future Directions. 
Prrx I and Snai2 candidate genes have shown a strong activation > l 000-fold of several 
fibroblast-specific genes and downstream gene that lead to strong repression of several liver­
specific genes. We did not determine whether this occurred due to Prrx 1 and Snai2 binding to the 
transcription factor promoters. This could be determined using software that predicts transcription 
factor binding sites (TFBS) paired with functional assays as such as ChIP and microarray to detect 
the binding site sequences of Prrx 1 and Snai2 on promoters. Also, we could be use prediction 
software such as systematic Evolution of Ligands by Exponential Enrichment (SELEX), which 
has been shown to be a powerful tool to detect the binding sites and the interactions of transcription 
factors. 
Gene knockdown experiments using RNAi could be used to reduce Prrxl and Snai2 
expression in the Fg14 cells and determine if fibroblast-specific genes and downstream gene have 
been affected or not. Additionally, comparisons between Prrx 1 and Snai2 expression during 
embryogenesis in normal and Prrx 1 and Snai2 with knockout mice model could help to clarify the 
role of the protein (Prrx I and Snai2) in fibroblast function. It would also be useful to conduct 
whole-genome microarray analysis on the Fg14 -Prrxl and Fg1 4-Snai2 cells compared to Fgl4 
cell and RA Tl cells to identify the extent of genomic remodeling that has occurred due to over 
expression of these genes Finally, these data would help us identify in vivo DNA-binding sites 
for downstream pathway proteins and provide a snapshot of the impact of these key TFs on the 
transcriptional activation/repression of interconnected TFS and other fibroblast-specific 
downstream targets. 
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